Chris is Finance and IT Director at ESPL and has been a director since 2011. In his role he manages the infrastructure needed to support the international regulatory team. Chris manages the Glasgow office and supports the medical device section of the business, with experience in QMS development and regulatory strategy.
Chris is Finance and IT Director at ESPL and has been a director since 2011. In his role he manages the infrastructure needed to support the international regulatory team. Chris manages the Glasgow office and supports the medical device section of the business, with experience in QMS development and regulatory strategy.
Helen has 30 years of Regulatory Affairs experience and founded ESPL in 2000. Before making the move into consulting, Helen gained experience working with ICI Pharmaceuticals (now Astro-Zeneca), Fisons and SmithKline Beecham (now GlaxoSmithKline). Helen has a broad experience in regulatory affairs and compliance, including product developments in NCE’s, the consumer sector, medical devices and borderline drug/device combinations as well as radiopharmaceuticals.
Jason is ESPL’s Managing Director and has over 20 years of experience in Regulatory Affairs in both industry and consultancy roles. After his postgraduate studies he began his regulatory career at Stiefel Laboratories in 1999, before moving to Allergy Therapeutics, where he progressed to managing the global regulatory affairs function. In 2011 he moved into consultancy, initially with RRG, and then joining ESPL in 2017. Jason has worked on a broad range of projects, including biologicals, particularly supporting pre-MAA activities. Jason has also gained Chartered Scientist recognition in Regulatory Affairs through TOPRA